Substrates and potential therapeutics of ventricular arrhythmias in heart failure

Dongze Zhang, Huiyin Tu, Michael C. Wadman, Yu Long Li

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Heart failure (HF) is a clinical syndrome characterized by ventricular contractile dysfunction. About 50% of death in patients with HF are due to fetal ventricular arrhythmias including ventricular tachycardia and ventricular fibrillation. Understanding ventricular arrhythmic substrates and discovering effective antiarrhythmic interventions are extremely important for improving the prognosis of patients with HF and reducing its mortality. In this review, we discussed ventricular arrhythmic substrates and current clinical therapeutics for ventricular arrhythmias in HF. Base on the fact that classic antiarrhythmic drugs have the limited efficacy, side effects, and proarrhythmic potentials, we also updated some therapeutic strategies for the development of potential new antiarrhythmic interventions for patients with HF.

Original languageEnglish (US)
Pages (from-to)349-356
Number of pages8
JournalEuropean Journal of Pharmacology
StatePublished - Aug 15 2018


  • Antiarrhythmic drugs
  • Catheter ablation
  • Heart failure
  • Ventricular arrhythmia
  • Ventricular arrhythmic substrate

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Substrates and potential therapeutics of ventricular arrhythmias in heart failure'. Together they form a unique fingerprint.

Cite this